Search Within

Nicole Alexa Schreiber

Formats
  1. Meeting Abstract (20)
  2. Journal Article (8)
Groups
  1. Department of Medicine (28)
  2. Genitourinary Oncology Service (28)
  3. Solid Tumor Oncology Division (28)
  4. Department of Pathology and Laboratory Medicine (20)
  5. Epidemiology and Biostatistics (9)
  6. Biostatistics Service (7)

More Groups

People
  1. Howard Scher (27)
  2. Martin Fleisher (17)
  3. Brigit McLaughlin (11)
  4. Daniel Danila (11)
  5. Glenn Heller (7)
  6. Richard Bambury (6)

More People

Years
  1. 2023 (1)
  2. 2020 (1)
  3. 2019 (1)
  4. 2018 (5)
  5. 2017 (5)
  6. 2016 (6)

More Years

Publications
  1. Journal of Clinical Oncology (13)
  2. Cancer Research (3)
  3. JAMA Oncology (3)
  4. Annals of Oncology (2)
  5. Cancer Prevention Research (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. American Association for Cancer Research (5)
  3. American Medical Association (3)
  4. Elsevier Science, Inc. (2)
  5. Oxford University Press (2)
  6. Elsevier Inc. (1)

More Publishers

Results (28)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Single cell analysis of AR N terminal, AR C terminal and the ARv7 splice variant in the CTCs of metastatic castration resistant prostate cancer (mCRPC) patients
    Meeting Abstract

    Kelvin, J.; Lu, D.; Packer, D.; Bambury, R.; Rathkopf, D.; Schreiber, N.; Arslan, Z.; Prigozhina, N.; Brown, D.; Krupa, R.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Presence of AR-V7 splice variant or AR C terminal loss in the CTCs of mCRPC patients identifies patients with improved PSA response with taxanes over androgen receptor signaling directed therapies (ARS Rx)
    Meeting Abstract

    Scher, H. I.; Kelvin, J.; Lu, D.; Louw, J.; Packer, D.; Bambury, R.; Rathkopf, D.; Schreiber, N.; Brennan, R.; Prigozhina, N.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Intra-patient genomic heterogeneity of single circulating tumor cells (CTCs) associated to phenotypic CTC heterogeneity in metastatic castrate resistant prostate cancer (mCRPC)
    Meeting Abstract

    Landers, M.; Greene, S.; Schreiber, N. A.; Rodriguez, A.; Bambury, R. M.; Danila, D. C.; Rathkopf, D. E.; Fleisher, M.; Louw, J.; Jendrisak, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • STEAP1 as a predictive biomarker for antibody-drug conjugate (ADC) activity in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Danila, D. C.; Fleisher, M.; Carrasquillo, J. A.; Gilbert, H.; Morris, M. J.; Bellomo, L. P.; Hendrikx, P. J.; Szafer-Glusman, E.; Herkal, A.; Patel, C.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Predictive biomarkers of sensitivity to androgen receptor signaling (ARS) and taxane-based chemotherapy in circulating tumor cells (CTCs) of patients (pts) with metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Scher, H. I.; Louw, J.; Jendrisak, A.; Bambury, R. M.; Danila, D. C.; Rathkopf, D. E.; Arslan, Z.; Schreiber, N. A.; Lu, D.; Krupa, R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Molecular characterization of circulating tumor cells (CTC) and CTC subpopulations in baseline and progressive metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Dittamore, R.; Louw, J.; Krupa, R.; Danila, D. C.; Arslan, Z.; Schreiber, N. A.; Bales, N.; Marrinucci, D.; Scher, H. I.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A pilot study comparing circulation tumor cells (CTC) detection by AdnaTest prostate assay to CellSearch in patients (pts) with castration resistant prostate cancer (CRPC)
    Meeting Abstract

    Samoila, A.; Bastos, D. A.; Herkal, A.; Patel, C.; Curtis, K. R.; Schreiber, N. A.; Anand, A.; Fleisher, M.; Scher, H. I.; Danila, D. C.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Validation of the aDNA test prostate assay sensitivity in detecting prostate-associated transcripts compared to the veridex cellsearch enumeration assay in patients with prostate sancer
    Meeting Abstract

    Samoila, A.; Bastos, D. A.; Anand, A.; Herkal, A.; Patel, C.; Curtis, K. R.; Schreiber, N.; Fleisher, M.; Scher, H. I.; Danila, D. C.
    Journal of Molecular Diagnostics (2013)

    Fulltext@MSK | Save